New evidence from the Prostate Cancer Prevention Trial may exculpate cyclooxygenase (COX) blockers in erectile dysfunction

BJU Int. 2016 Mar;117(3):385-6. doi: 10.1111/bju.13343.

Authors

Alexander P Cole¹, Jeffrey J Leow¹, Quoc-Dien Trinh²

Affiliations

¹ Center for Surgery and Public Health, Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Center for Surgery and Public Health, Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. trinh.qd@gmail.com.

PMID: 26876900
DOI: 10.1111/bju.13343

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Erectile Dysfunction / chemically induced*
Humans
Male
Prostatic Neoplasms / prevention & control*

Substances

Anti-Inflammatory Agents, Non-Steroidal